{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:32:59Z","timestamp":1784759579050,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ERASMUS program","award":["M01-L207"],"award-info":[{"award-number":["M01-L207"]}]},{"DOI":"10.13039\/100008573","name":"CAC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmech.2018.06.028","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T10:37:27Z","timestamp":1529059047000},"page":"772-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Dihydropyrimidinone\/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation"],"prefix":"10.1016","volume":"155","author":[{"given":"Hanane","family":"Kaoukabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Kabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Curti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moha","family":"Taourirte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Rodriguez-Ubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Vanelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan B.","family":"Lazrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.06.028_bib1","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Arvin","year":"2007"},{"key":"10.1016\/j.ejmech.2018.06.028_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.06.028_bib3","first-page":"15","article-title":"The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic","volume":"12","author":"Barton","year":"2005","journal-title":"Herpesviridae"},{"key":"10.1016\/j.ejmech.2018.06.028_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/14756366.2013.845820","article-title":"Synthesis and characterization of quinazoline derivatives: search for hybrid molecule as diuretic and antihypertensive agents","volume":"29","author":"Rahman","year":"2014","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/11597630-000000000-00000","article-title":"Hybrid compounds: from simple combinations to nanomachines","volume":"26","author":"M\u00fcller-Schiffmann","year":"2012","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejmech.2018.06.028_bib6","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1016\/j.bmcl.2012.07.038","article-title":"Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents","volume":"22","author":"Husain","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.06.028_bib7a","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib7b","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2014.02.029","article-title":"1,2,3-triazole-containing derivatides of rupestonic acid : click-chemical synthesis and antiviral activities against influenza viruses","volume":"76","author":"He","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib7c","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00044-013-0762-6","article-title":"Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs","volume":"23","author":"de Lourdes","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.06.028_bib7d","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15257770.2015.1115523","article-title":"Synthesis and bioactivity of novel trisubstituted triazole nucleosides","volume":"35","author":"Wen","year":"2016","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2018.06.028_bib7e","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bmc.2011.02.007","article-title":"Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives","volume":"19","author":"Jordao","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib8a","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ejmech.2017.10.073","article-title":"Biological activity of dihydropyrimidinone (DHPM) derivatives: a systematic review","volume":"143","author":"Matos","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib8b","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2017.03.025","article-title":"Recent synthetic and medicinal perspectives of dihydropyrimidinones. A review","volume":"132","author":"Kaur","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib8c","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1021\/jm000210m","article-title":"Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain","volume":"43","author":"McGuigan","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib8d","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.bmcl.2012.01.133","article-title":"A\u00a0novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability","volume":"22","author":"Kim","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.06.028_bib9","first-page":"1317","article-title":"Ueber Aldehyduramide des Acetessig\u00e4thers. II","volume":"24","author":"Biginelli","year":"1891","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib10","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1081\/NCN-120026399","article-title":"Synthesis of 3-Deoxy-3\u2032-[4-(pyrimidin-1-yl) methyl-1,2,3-triazol-1-yl]thymidine via 1,3-Dipolar Cycloaddition","volume":"22","author":"Taourirte","year":"2003","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2018.06.028_sref9","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1016\/j.tetlet.2006.06.015","article-title":"Phenylboronic acid as a mild and efficient catalyst for Biginelli reaction","volume":"47","author":"Debache","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.06.028_bib11b","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1246\/cl.2004.1168","article-title":"A\u00a0novel l-proline catalyzed Biginelli reaction: one-pot synthesis of 3, 4-dihydropyrimidin-2 (1 H)-ones under solvent-free conditions","volume":"33","author":"Yadav","year":"2004","journal-title":"Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.06.028_bib11c","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1016\/S0040-4039(03)01466-7","article-title":"One-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones using boric acid as catalyst","volume":"44","author":"Tu","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.06.028_bib12a","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1080\/00397910500213963","article-title":"Lewis acid\u2013doped natural phosphate: new catalysts for the one-pot synthesis of 3,4-Dihydropyrimdin-2(1H)-one","volume":"35","author":"El Badaoui","year":"2005","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2018.06.028_bib12b","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1570178054640750","article-title":"One-pot synthesis of 3,4-Dihydropyrimidin-2(1H)-ones using ZnCl2, CuCl2, NiCl2 and CoCl2 doped hydroxyapatite","volume":"2","author":"El Badaoui","year":"2005","journal-title":"Lett. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.06.028_bib12c","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.catcom.2005.04.003","article-title":"Synthesis of 3,4-dihydropyrimidin-2-ones catalysed by fluorapatite doped with metal halides","volume":"6","author":"El Badaoui","year":"2005","journal-title":"Catal. Commun."},{"key":"10.1016\/j.ejmech.2018.06.028_bib13a","doi-asserted-by":"crossref","first-page":"x170816","DOI":"10.1107\/S2414314617008161","article-title":"5-Acetyl-4-(2,5-dimethoxyphenyl)-6-methyl-1-(prop-2-ynyl)-3,4-dihydropyrimidin-2(1H)-one","volume":"2","author":"Kaoukabi","year":"2017","journal-title":"IUCrData"},{"key":"10.1016\/j.ejmech.2018.06.028_bib13b","doi-asserted-by":"crossref","first-page":"x171802","DOI":"10.1107\/S2414314617018028","article-title":"5-Acetyl-6-methyl-4-phenyl-1-(prop-2-ynyl)-3,4-dihydropyrimidin-2(1H)-one","volume":"2","author":"Kaoukabi","year":"2017","journal-title":"IUCrData"},{"key":"10.1016\/j.ejmech.2018.06.028_bib14","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/chem.200601463","article-title":"Chiral amnesia\u201d as a driving force for solid-phase homochirality","volume":"13","author":"Blackmond","year":"2007","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2018.06.028_bib15a","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ardp.201300260","article-title":"Synthesis of 1,2,3-triazolyl nucleoside analogs as potential anti-influenza A (H3N2 subtype) virus agents","volume":"347","author":"Elayadi","year":"2014","journal-title":"Pharm. Chem.Life Sci."},{"key":"10.1016\/j.ejmech.2018.06.028_bib15b","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2007.08.077","article-title":"Efficient synthesis and in\u00a0vitro cytostatic activity of 4-substituted triazolyl-nucleosides","volume":"17","author":"El Akri","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.06.028_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bmcl.2014.12.087","article-title":"Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents","volume":"25","author":"Ma","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.06.028_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3851\/IMP2533","article-title":"Selective anti-herpesvirus agents","volume":"23","author":"De Clercq","year":"2013","journal-title":"Antivir. Chem. Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418305191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418305191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T18:44:00Z","timestamp":1569091440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418305191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":30,"alternative-id":["S0223523418305191"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.028","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydropyrimidinone\/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}